Rockefeller Capital Management
OPRX icon

Rockefeller Capital Management’s OptimizeRx OPRX Stock Holding History

Rockefeller Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9
Closed – – 3295
2022
Q4 		$0 Sell
9
-3,500
-100% -$60.5K ﹤0.01% 4113
2022
Q3 		$52K Sell
3,509
-129
-4% -$2.55K ﹤0.01% 2324
2022
Q2 		$99K Buy
3,638
+138
+4% +$4.09K ﹤0.01% 1953
2022
Q1 		$131K Buy
+3,500
New +$155K ﹤0.01% 1869

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rockefeller Capital Management's OPRX Position: Q1 2023 in Review

Rockefeller Capital Management sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 9 shares.

Rockefeller Capital Management first reported a position in OPRX in Q1 2022 and held it in 4 quarters. The position peaked at $131K in Q1 2022. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

  • Rockefeller Capital Management reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 9 OptimizeRx shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in OptimizeRx in Q1 2022 and held it in 4 quarters.
  • Rockefeller Capital Management's OptimizeRx position peaked at $131K in Q1 2022.
  • 110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.